There are 2867 resources available
573P - Role of CA125 in patients included in the DESKTOP III/ENGOT-ov20 trial
Presenter: Fabrice Lecuru
Session: Poster session 09
574P - Myriad MyChoice plus intermediate performance to discriminate platinum-resistant high-grade ovarian cancer patients
Presenter: Felix Blanc-Durand
Session: Poster session 09
575P - Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade serous or endometrioid ovarian cancer: A multi-national observational study
Presenter: Robert Morgan
Session: Poster session 09
576P - Genome instability index used for the optimization of molecular classification of endometrial carcinoma
Presenter: Min Gao
Session: Poster session 09
577P - Impact of homologous recombination deficiency (HRD) on outcomes with intraperitoneal (IP) and intravenous (IV) chemotherapy in ovarian cancer: Analyses from the translational iPocc study (TriPocc)
Presenter: Silvana Wijaya
Session: Poster session 09
578P - Genotype-phenotype correlation in diverse pathogenic variants in BRCA genes in patients with ovarian cancer: Focusing in prognosis and predictive role of each one
Presenter: Eva Maria Gomez Garcia
Session: Poster session 09
579P - A multicenter evaluation of a low pass whole genome sequencing-based solution for homologous recombination deficiency detection
Presenter: Adrien Buisson
Session: Poster session 09
580P - Physician behaviour and perceptions of genetic biomarker test use for the management of newly diagnosed advanced ovarian cancer patients
Presenter: Giorgio Valabrega
Session: Poster session 09
581P - Homologous recombination deficiency (HRD) in 543 ovarian cancer samples: A single center hands-on experience
Presenter: Athanasios Kotsakis
Session: Poster session 09
582P - Longitudinal, multi-sample characterization of HGSC from DECIDER: A Finnish observational study
Presenter: Jaana Oikkonen
Session: Poster session 09